Patent · US Active

Thioether derivatives as protein kinase inhibitors

US9925193B2 · kind B2 · utility

0Cited by

4References

7Claims

0Family size

Assignee

ProQinase GmbH · DE

Inventors

Michael Kubbutat · Schallstadt, DE
Christoph Schachtele · Glückstadt, DE
Jan Ehlert · Ehrenkirchen, DE
Frank Totzke · Glückstadt, DE
Conrad Kunick · Hamburg, DE
Sebastian Wolfel · Braunschweig, DE
Holger WEBER · Glückstadt, DE

Key dates

Filing date	Nov 11, 2013
Grant date	Mar 27, 2018
Priority date	—
Expiry date	Nov 11, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to thioether derivatives (1) as protein kinase inhibitors, which are useful for the treatment, relieve and/or prevention of diseases associated with abnormal and hyperproliferation of cells in a mammal, especially humans, and which are particularly useful for the treatment of all forms of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.